Belumosudil is a selective inhibitor of Rho-associated, coiled-coil containing protein kinase (ROCK2) used in the treatment of chronic graft-versus-host disease. This oral small molecule medication modulates… Read more











Belumosudil is a selective inhibitor of Rho-associated, coiled-coil containing protein kinase (ROCK2) used in the treatment of chronic graft-versus-host disease. This oral small molecule medication modulates inflammatory and fibrotic processes to help restore immune homeostasis. This category provides high-quality reference standards of the active pharmaceutical ingredient (API), as well as critical related compounds essential for drug development and analytical testing. Laboratories utilize these materials, including specified impurities, degradation products, and metabolic conjugates such as glucuronides, to facilitate comprehensive impurity profiling and rigorous quality control. Furthermore, stable isotope labelled compounds are available to serve as reliable internal standards for quantitative bioanalysis and method validation. These analytical tools enable the precise identification and quantification of impurities and metabolites during pharmaceutical manufacturing and stability testing, ensuring compliance with regulatory standards for therapeutic efficacy and safety.